文献速递分子诊断质量管理与危急值

BK病毒核酸扩增检测溯源至WHO国际标准品的校准研究

Calibration of BK Virus Nucleic Acid Amplification Testing to the 1st WHO International Standard for BK Virus.
PubMed 文献 · J Clin Microbiol · 2017-01-04

本研究评估Altona RealStar BKV检测,并通过可溯源至WHO国际标准品的二级标准品将结果校准至国际单位(IU)。原级与二级标准品在Altona上的线性回归方程及转换因子几乎一致,以IU/ml报告结果可显著降低与实验室自建检测法之间的系统偏倚。

要点

  • 原级与二级标准品在Altona上的回归方程与转换因子高度一致。
  • 以IU/ml报告结果时,两种方法间系统偏倚较copies/ml显著减小。
  • 采用共同校准品可改善BK病毒核酸扩增检测方法间的一致性。

核心结论

  • 使用可溯源至WHO国际标准品的共同校准品可改善BK病毒核酸扩增检测方法间的一致性。

研究设计与样本

  • 评估Altona RealStar BKV检测,并使用可溯源至原级标准品的Exact Diagnostics BKV验证盘进行IU校准。

主要发现

  • 原级标准品回归方程为Y = 1.05X - 0.28(R2 = 0.99),转换因子1.11 IU/copy。
  • 二级标准品回归方程为Y = 1.04X - 0.26(R2 = 0.99),转换因子1.09 IU/copy。
  • Passing-Bablok回归显示以IU/ml报告时无比例偏倚且系统偏倚改善(截距95%CI:0.07至-0.36)。
  • Bland-Altman分析显示以IU/ml报告时偏倚为-0.10 log10,以copies/ml报告时为-0.70 log10。

临床怎么用

  • 临床实验室应采用可溯源至WHO国际标准品的校准品报告BK病毒DNA结果,以改善方法间可比性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Significant interassay variability in the quantification of BK virus (BKV) DNA precludes establishing broadly applicable thresholds for the management of BKV infection in transplantation. The 1st WHO International Standard for BKV (primary standard) was introduced in 2016 as a common calibrator for improving the harmonization of BKV nucleic acid amplification testing (NAAT) and enabling comparisons of biological measurements worldwide. Here, we evaluated the Altona RealStar BKV assay (Altona) and calibrated the results to the international unit (IU) using the Exact Diagnostics BKV verification panel, a secondary standard traceable to the primary standard. The primary and secondary standards on Altona had nearly identical linear regression equations (primary standard, Y = 1.05X - 0.28, R2 = 0.99; secondary standard, Y = 1.04X - 0.26, R2 = 0.99) and conversion factors (primary standard, 1.11 IU/copy; secondary standard, 1.09 IU/copy). A comparison of Altona with a laboratory-developed BKV NAAT assay in IU/ml versus copies/ml using Passing-Bablok regression revealed similar regression lines, no proportional bias, and improvement in the systematic bias (95% confidence interval of intercepts: copies/ml, -0.52 to -1.01; IU/ml, 0.07 to -0.36). Additionally, Bland-Altman analyses revealed a clinically significant reduction of bias when results were reported in IU/ml (IU/ml, -0.10 log10; copies/ml, -0.70 log10). These results indicate that the use of a common calibrator improved the agreement between the two assays. As clinical laboratories worldwide use calibrators traceable to the primary standard to harmonize BKV NAAT results, we anticipate improved interassay comparisons with a potential for establishing broadly applicable quantitative BKV DNA load cutoffs for clinical practice.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Tan SK, Milligan S, Sahoo MK, et al. Calibration of BK Virus Nucleic Acid Amplification Testing to the 1st WHO International Standard for BK Virus. J Clin Microbiol. 2017. PMID: 28053213. doi:10.1128/JCM.02315-16

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。